false
Catalog
Culturally-Informed Psychopharmacology for Patient ...
Presentation Slides
Presentation Slides
Back to course
Pdf Summary
This document is a summary of a presentation on culturally-informed psychopharmacology for patients with mood disorders. The presentation is part of the Clinical Support System for Serious Mental Illness (CSS-SMI), a collaboration between the Substance Abuse and Mental Health Services Administration (SAMHSA) and the American Psychiatric Association (APA).<br /><br />The presentation begins with an introduction to the initiative and the faculty involved. It then covers the learning objectives, which include identifying mental health disparities in prescribing for diverse populations with mood disorders and incorporating culturally sensitive techniques in prescribing.<br /><br />The document also includes a land acknowledgment statement, recognizing and paying respect to Native American and Indigenous Peoples. It highlights the importance of diversity and different life experiences in reaching equity.<br /><br />The presentation discusses the impact of COVID-19 on mental health in communities of color and the social and cultural determinants of health. It also touches on the concept of cumulative stress and trauma and the need for safe and brave spaces for discussion.<br /><br />The document emphasizes the importance of bias awareness and provides a developmental hierarchy for understanding and addressing unconscious biases. Strategies for developing clinical brave spaces are outlined, including setting the tone, inquiring about sociocultural information, and using moments of discomfort to deepen understanding.<br /><br />The presentation discusses the concept of precision health and sociocultural conversation in psychopharmacology. It explores how genetics, environment, and culture can affect medication responses and highlights the benefits of using pharmacogenetic testing to personalize care and promote health equity.<br /><br />Scenarios are presented to illustrate the application of precision health and sociocultural conversation in prescribing for adult and child patients. The document concludes with a summary of the key points discussed and references for further reading.<br /><br />Overall, the presentation aims to promote culturally informed practices in psychopharmacology and encourage healthcare providers to recognize and address disparities in mental health care.
Keywords
culturally-informed psychopharmacology
mood disorders
Clinical Support System for Serious Mental Illness
SAMHSA
APA
mental health disparities
diverse populations
cultural sensitivity
COVID-19 impact on mental health
pharmacogenetic testing
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
×
Please select your language
1
English